Pathological antibody-mediated rejection in pediatric heart transplant recipients: Immunologic risk factors, hemodynamic significance, and outcomes.

@article{Hollander2018PathologicalAR,
  title={Pathological antibody-mediated rejection in pediatric heart transplant recipients: Immunologic risk factors, hemodynamic significance, and outcomes.},
  author={Seth A Hollander and David M Peng and Marcos Mills and Gerald J. Berry and Marny Fedrigo and Doff B McElhinney and Christopher S D Almond and David N. Rosenthal},
  journal={Pediatric transplantation},
  year={2018},
  volume={22 5},
  pages={
          e13197
        }
}
Biopsy-diagnosed pAMR has been observed in over half of pediatric HT recipients within 6 years of transplantation. We report the incidence and outcomes of pAMR at our center. All endomyocardial biopsies for all HT recipients transplanted between 2010 and 2015 were reviewed and classified using contemporary ISHLT guidelines. Graft dysfunction was defined as… CONTINUE READING